Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × anlotinib × Clear all

Phase

Status

Unknown 4 Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Pancreatic Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Medullary 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advanced Malignancy 1 Advanced Cancer 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 105 Oxaliplatin 100 Fluorouracil 88 Capecitabine 84 Docetaxel 62 Leucovorin 55 Irinotecan 52 Paclitaxel 46 S 1 (combination) 36 pembrolizumab 27 Trastuzumab 25 Radiotherapy 24 Bevacizumab 19 titanium silicide 17 Nivolumab 17 Epirubicin 17 Carboplatin 17 Surgical Procedures, Operative 14 Ramucirumab 14 Cetuximab 14 Gastrectomy 13 apatinib 11 Gemcitabine 9 Everolimus 9 Albumin-Bound Paclitaxel 9 Mitomycin 7 Folfox protocol 7 Drug Therapy 7 Cyclophosphamide 7 camrelizumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04963088 2025-06-26

TALENT

The First Affiliated Hospital with Nanjing Medical University

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡